Title of article
Discovery of a novel series of inhibitors of human cytomegalovirus primase
Author/Authors
T.D. Cushing، نويسنده , , J. Adrian، نويسنده , , X. Chen، نويسنده , , H. DiMaio، نويسنده , , B. Doughan، نويسنده , , J. Flygare، نويسنده , , L. Liang، نويسنده , , V. Mayorga، نويسنده , , S. Miao، نويسنده , , H. Mellon، نويسنده , , M.G. Peterson، نويسنده , , J.P. Powers، نويسنده , , F. Spector، نويسنده , , C. Stein، نويسنده , , M. Wright، نويسنده , , D. Xu، نويسنده , , Q. Ye، نويسنده , , J. Jaen، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2006
Pages
5
From page
4879
To page
4883
Abstract
Infection by human cytomegalovirus (hCMV) remains a potent threat to susceptible people throughout the world. We have discovered a series of imidazolyl-pyrimidine compounds, which were found to be irreversible inhibitors of the hCMV UL70 primase based on results from radiolabeling and SAR studies. Two promising analogs are described that rival ganciclovir and cidofovir in antiviral potency and possess improved cytotoxicity profiles.
Keywords
Radiolabeling , Tritiation , CMV , Cytomegalovirus , Ganciclovir , Imidazolyl-pyrimidine , Cidofovir , Irreversible inhibitor , UL70 primase
Journal title
Bioorganic & Medicinal Chemistry Letters
Serial Year
2006
Journal title
Bioorganic & Medicinal Chemistry Letters
Record number
797298
Link To Document